These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25440624)

  • 1. Bilateral lung transplantation in a patient receiving rivaroxaban anticoagulation.
    Renner TA; Zalunardo MP; Weder W; Spahn DR
    J Cardiothorac Vasc Anesth; 2015; 29(3):723-6. PubMed ID: 25440624
    [No Abstract]   [Full Text] [Related]  

  • 2. Postoperative bleeding risk for oral surgery under continued rivaroxaban anticoagulant therapy.
    Hanken H; Gröbe A; Heiland M; Smeets R; Kluwe L; Wikner J; Koehnke R; Al-Dam A; Eichhorn W
    Clin Oral Investig; 2016 Jul; 20(6):1279-82. PubMed ID: 26498769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Livedoid Vasculopathy With Rivaroxaban: A Potential Use of New Oral Anticoagulants for Dermatologists.
    Jiménez-Gallo D; Villegas-Romero I; Rodríguez-Mateos ME; Linares-Barrios M
    Actas Dermosifiliogr (Engl Ed); 2018 Apr; 109(3):278-281. PubMed ID: 29074145
    [No Abstract]   [Full Text] [Related]  

  • 4. Greenlight™ photovaporization of the prostate in patients under rivaroxaban: Lesson learned after the first cases.
    Charbonneau H; Pathak A; Albenque JP; Misrai V
    Prog Urol; 2016 Apr; 26(5):273-5. PubMed ID: 26970929
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety of dabigatran or rivaroxaban for thoracoscopic ablation in patients with atrial fibrillation.
    Im SI; Jeong DS; Park SJ; Park KM; Huh J; Kim JS; On YK
    Int J Cardiol; 2015; 186():213-5. PubMed ID: 25828118
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimizing the Safe Use of Direct Oral Anticoagulants in Older Patients: A Teachable Moment.
    Sennesael AL; Dogné JM; Spinewine A
    JAMA Intern Med; 2015 Oct; 175(10):1608-9. PubMed ID: 26237648
    [No Abstract]   [Full Text] [Related]  

  • 7. Performance of coagulation tests in patients on therapeutic doses of rivaroxaban. A cross-sectional pharmacodynamic study based on peak and trough plasma levels.
    Francart SJ; Hawes EM; Deal AM; Adcock DM; Gosselin R; Jeanneret C; Friedman KD; Moll S
    Thromb Haemost; 2014 Jun; 111(6):1133-40. PubMed ID: 24401946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of rivaroxaban versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a meta-analysis of observational studies.
    Li W; Gao C; Li M; Wang X; Qi D; Zhang Y; Hao P; Liu J; Zhu L
    Discov Med; 2015 Mar; 19(104):193-201. PubMed ID: 25828523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation with a new oral anticoagulant in heart transplant recipients.
    Ambrosi P; Kreitmann B; Cohen W; Habib G; Morange P
    Int J Cardiol; 2013 Oct; 168(4):4452-3. PubMed ID: 23890900
    [No Abstract]   [Full Text] [Related]  

  • 10. Tonsillectomy on rivaroxaban.
    Saini AT; Schorn VJ; Lin FY
    Am J Otolaryngol; 2015; 36(2):280-2. PubMed ID: 25456169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivaroxaban in acute coronary syndromes--is it prime time?
    Asrar ul Haq M; van Gaal WJ
    Expert Rev Cardiovasc Ther; 2014 Jun; 12(6):649-58. PubMed ID: 24746010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement.
    Eriksson BI; Borris LC; Dahl OE; Haas S; Huisman MV; Kakkar AK; Muehlhofer E; Dierig C; Misselwitz F; Kälebo P;
    Circulation; 2006 Nov; 114(22):2374-81. PubMed ID: 17116766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of direct oral anticoagulants in patients with left ventricular thrombus.
    Chen K; Yu S; Zhu W; Liu X
    Eur J Intern Med; 2024 Aug; 126():132-133. PubMed ID: 38679498
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial).
    Bansilal S; Bloomgarden Z; Halperin JL; Hellkamp AS; Lokhnygina Y; Patel MR; Becker RC; Breithardt G; Hacke W; Hankey GJ; Nessel CC; Singer DE; Berkowitz SD; Piccini JP; Mahaffey KW; Fox KA;
    Am Heart J; 2015 Oct; 170(4):675-682.e8. PubMed ID: 26386791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rivaroxaban - Largest Study Program with novel oral anticoagulants].
    van Eickels M
    Dtsch Med Wochenschr; 2015 Jun; 140 Suppl 1():S27. PubMed ID: 26069045
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nosebleed in new oral anticoagulant treatment - what should be done?].
    Stiefelhagen P
    MMW Fortschr Med; 2015 Sep; 157(15):25. PubMed ID: 26349711
    [No Abstract]   [Full Text] [Related]  

  • 17. Intracranial bleedings in patients on long-term anticoagulant treatment: Benefits from oral thrombin and factor Xa inhibitors in clinical practice.
    Łukasik M; Zawilska K; Undas A
    Neurol Neurochir Pol; 2015; 49(3):171-9. PubMed ID: 26048605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rivaroxaban inhibits oxidative and inflammatory reactions in advanced glycation end product-exposed tubular cells by blocking thrombin/protease-activated receptor-2 system.
    Ishibashi Y; Matsui T; Fukami K; Ueda S; Okuda S; Yamagishi S
    Thromb Res; 2015 Apr; 135(4):770-3. PubMed ID: 25636461
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel Oral Anticoagulants for DC Cardioversion Procedures: Utilization and Clinical Outcomes Compared with Warfarin.
    Coleman CM; Khalaf S; Mould S; Wazni O; Kanj M; Saliba W; Cantillon D
    Pacing Clin Electrophysiol; 2015 Jun; 38(6):731-7. PubMed ID: 25721150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-coagulation assessment with prothrombin time and anti-Xa assays in real-world patients on treatment with rivaroxaban.
    Königsbrügge O; Quehenberger P; Belik S; Weigel G; Seger C; Griesmacher A; Pabinger I; Ay C
    Ann Hematol; 2015 Sep; 94(9):1463-71. PubMed ID: 26025632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.